By considering stability as part of the cell line selection and cell banking paradigm, we can ensure that instability problems are not observed during clinical or commercial manufacturing.
Cecilia Cooley
Advertisement
Cecilia Cooley is a research scientist I in the cell and molecular sciences group in the department of Drug Substance Development at Wyeth Biopharma
Articles by Cecilia Cooley
Advertisement
Latest Updated Articles
Advertisement
Advertisement